Publications by authors named "Adrien Dixmier"

Claim this Profile
F
Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer.
Fabrice Barlesi, Adrien Dixmier, Didier Debieuvre, Christophe Raspaud, Jean-Bernard Auliac

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FRESC: French Real world Extensive stage SCLC Cohorts: A retrospective study on patient characteristics and treatment strategy based on KBP-2010.
Didier Debieuvre, Charles Dayen, Adrien Dixmier, David Pau, Anna Sibley-Revelat

Lung Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada.
Didier Debieuvre, Rosalyn A Juergens, Bernard Asselain, Clarisse Audigier-Valette, Jean-Bernard Auliac, Adrien Dixmier

Lung Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non-small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study.
Alexis B Cortot, Clarisse Audigier-Valette, Olivier Molinier, Sylvestre Le Moulec, Fabrice Barlesi, Adrien Dixmier

Eur J Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study.
Fabrice Barlesi, Adrien Dixmier, Didier Debieuvre, Christophe Raspaud, Jean-Bernard Auliac

Oncoimmunology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women and COPD: do we need more evidence?
Christophe Gut-Gobert, Arnaud Cavaillès, Adrien Dixmier, Stéphanie Guillot, Stéphane Jouneau

Eur Respir Rev· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.
Guy Meyer, Benjamin Besse, Hélène Doubre, Anaïs Charles-Nelson, Sandro Aquilanti, Adrien Dixmier

Eur Respir J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between lung cancer somatic mutations and occupational exposure in never-smokers.
Christophe Paris, Pascal Do, Bénédicte Mastroianni, Adrien Dixmier, Patrick Dumont

Eur Respir J· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Sébastien Couraud, Pierre-Jean Souquet, Christophe Paris, Pascal Dô, Hélène Doubre, Adrien Dixmier

Eur Respir J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities of COPD.
Arnaud Cavaillès, Graziella Brinchault-Rabin, Adrien Dixmier, François Goupil, Christophe Gut-Gobert

Eur Respir Rev· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aseptic meningitis associated with intravenous administration of dexchlorpheniramine.
Matthieu Lafaurie, Adrien Dixmier, Jean-Michel Molina

Ann Med Interne (Paris)· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis